RecruitingNot a traditional drug phaseinterventionalRules rewrite

Not a traditional drug phase: Intuitive Eating Intervention for Excessive Gestational Weight Gain

Q: Is NCT07792837 still recruiting?

The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.

Q: What phase is NCT07792837?

Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

Q: Can PlainTrials tell me if I qualify for NCT07792837?

No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.

The goal of this feasibility randomly assigned controlled trial is to assess the feasibility, acceptability, and demand, as well as preliminary effects of an evidence-based Intuitive Eating (IE) intervention among pregnant women who have obesity. The main research questions are: RQ1: What is the feasibility (acceptability and demand) of implementing an Intuitive Eating Intervention among pregnant and postpartum women?

Official registry: https://clinicaltrials.gov/study/NCT07792837 · San Diego State University · enrollment listed as 80

What this phase means

This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.

Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

What the registry says happens

If you join, the listed intervention(s) are Intuitive Eating Intervention. The registry lists allocation as randomized. The goal of this feasibility randomly assigned controlled trial is to assess the feasibility, acceptability, and demand, as well as preliminary effects of an evidence-based Intuitive Eating (IE) intervention among pregnant women who have obesity.

They plan to enroll about 80 people at 2 sites. Taking part typically means study visits and measurements plus check-ins.

Official title (unrewritten)

Feasibility and Preliminary Effects of an Online Intuitive Eating Intervention on Gestational Weight Gain and Well-Being in Pregnant Women

Interventions: Intuitive Eating Intervention

Primary outcome (registry wording): Intervention Acceptability as Assessed by the Post-Intervention Satisfaction Survey at 8 Weeks

Who it is for (from inclusion criteria)

Ages 18 Years to any
Women only
Pregnant women between 12 weeks and \<22 weeks gestation
Pre-pregnancy body-mass index (BMI) 30.0 kg/m² or greater
Able to read and understand English (for intervention materials and questionnaires)
Receiving prenatal care at UC San Diego Health (UCSD)
Reliable access to a device (e.g., smartphone, tablet, or computer) with internet connection

Who the registry excludes

Current or past diagnosis of an eating disorder (e.g., anorexia nervosa, bulimia nervosa, binge eating disorder, ARFID)
High-risk pregnancy or medical complications that may significantly affect diet, physical activity, or weight gain (e.g., gestational diabetes requiring insulin, preeclampsia, hyperemesis gravidarum)
Multiple gestation pregnancy (e.g., twins or higher-order multiples)
Current participation in another nutrition, weight management, or behavioral intervention study
Severe psychiatric illness (e.g., schizophrenia, bipolar disorder) or current substance use disorder that would interfere with participation

Public study contact (from the registry)

Jeni Green, PhD

619-594-6489

jgreen5@sdsu.edu

Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.

Sites listed on ClinicalTrials.gov

2 listed

San Diego State University — San Diego, California (recruiting)
UC San Diego Health — San Diego, California (recruiting)

Related recruiting trials in this snapshot

RecruitingPhase 2Bethesda, Maryland

Phase 2: testing Fluoxetine for Anxiety Disorders

Study Description: This study examines relations between neurocognitive and clinical features of pediatric anxiety disorders. The study uses neuro-cognitive tasks, functional magnetic resonance imaging (fMRI), as well as magneto- and electro-encephalography (M/EEG).

NCT00018057 · Official ClinicalTrials.gov record · National Institute of Mental Health (NIMH)

RecruitingNot a traditional drug phaseSioux Falls, South Dakota

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

The Coordination of Rare Diseases at Sanford (CoRDS) is an international patient registry that serves as a centralized resource for rare disease research. Individuals affected by rare diseases, undiagnosed conditions, and disorders of unknown prevalence may voluntarily contribute health information to support natural history studies, participant recruitment, and other research efforts.

NCT01793168 · Official ClinicalTrials.gov record · Sanford Health

RecruitingPhase 2Bethesda, Maryland

Phase 2: testing Ketamine Hydrochloride for Healthy Volunteers

Background: There are no good treatments for people considering suicide. Researchers want to study suicide with questions, blood tests, brain imaging, and sleep studies.

NCT02543983 · Official ClinicalTrials.gov record · National Institute of Mental Health (NIMH)

FAQ about this NCT record

Is NCT07792837 still recruiting?

The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.

What phase is NCT07792837?

Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

Can PlainTrials tell me if I qualify for NCT07792837?

No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.

How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary